On Oct 14 2025, OSR Holdings, Inc. (NASDAQ: OSRH) announced that it has entered into a definitive agreement to acquire Woori IO Co., Ltd., a South Korean developer of noninvasive glucose‑monitoring technology. The deal will make Woori IO a wholly‑owned subsidiary of OSR Holdings’ Korean affiliate, OSR Holdings Co., Ltd. (OSRK).
Under the terms of the agreement, Woori IO shareholders will receive newly issued OSRK shares valued at KRW 15 billion (approximately $10.5 million) in exchange for their Woori IO shares. If OSRH’s share price reaches at least $10 per share within three years of the exchange, the OSRK shares may be converted into OSRH common stock at a ratio of 12.96:1, or roughly 1.09 million new OSRH shares. The transaction is structured to avoid immediate dilution for existing OSRH shareholders.
The acquisition adds a needle‑free, near‑infrared spectroscopy (NIRS)‑based glucose‑monitoring platform to OSRH’s portfolio, positioning the company to capture recurring revenue in the fast‑growing continuous glucose‑monitoring market. CEO Peter Hwang emphasized that the transaction, valued at less than $11 million, represents an undervalued opportunity compared with multi‑billion‑dollar CGM peers and will accelerate product development and commercialization through OSRH’s global resources.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.